Gilead Sciences Inc. (GILD) Social Stream
GILEAD SCIENCES INC (GILD) Price Targets From Analysts
Use the tables below to see what analysts covering GILEAD SCIENCES INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-14 | 17 | $100 | $63 | $78.5 | $86.26 | -9% |
| 2021-11-19 | 18 | $100 | $63 | $79.428 | $86.26 | -7.92% |
| 2021-12-07 | 18 | $100 | $63 | $79.266 | $86.26 | -8.11% |
| 2021-12-14 | 19 | $100 | $63 | $78.812 | $86.26 | -8.63% |
| 2021-12-22 | 19 | $100 | $63 | $79.125 | $86.26 | -8.27% |
| 2022-01-07 | 18 | $100 | $63 | $79.25 | $86.26 | -8.13% |
| 2022-01-10 | 17 | $100 | $72 | $80.714 | $86.26 | -6.43% |
| 2022-01-25 | 17 | $100 | $72 | $80.571 | $86.26 | -6.6% |
| 2022-02-01 | 18 | $100 | $72 | $80.571 | $86.26 | -6.6% |
| 2022-02-02 | 18 | $100 | $71 | $79.714 | $86.26 | -7.59% |
| 2022-02-03 | 18 | $88 | $69 | $77.307 | $86.26 | -10.38% |
| 2022-02-18 | 18 | $90 | $69 | $78.214 | $86.26 | -9.33% |
| 2022-03-07 | 18 | $90 | $65 | $77.5 | $86.26 | -10.16% |
| 2022-03-16 | 18 | $90 | $65 | $77.142 | $86.26 | -10.57% |
| 2022-04-04 | 15 | $90 | $65 | $76 | $86.26 | -11.89% |
| 2022-04-12 | 15 | $90 | $63 | $75.083 | $86.26 | -12.96% |
| 2022-04-17 | 15 | $90 | $63 | $74.75 | $86.26 | -13.34% |
| 2022-04-29 | 15 | $90 | $63 | $74.083 | $86.26 | -14.12% |
| 2022-05-14 | 15 | $90 | $63 | $74.166 | $86.26 | -14.02% |
| 2022-05-16 | 15 | $90 | $63 | $73.833 | $86.26 | -14.41% |
| 2022-06-05 | 16 | $90 | $63 | $72.769 | $86.26 | -15.64% |
| 2022-08-03 | 17 | $90 | $65 | $72.857 | $86.26 | -15.54% |
| 2022-08-04 | 17 | $90 | $65 | $72.923 | $86.26 | -15.46% |
| 2022-08-14 | 17 | $90 | $65 | $72.571 | $86.26 | -15.87% |
| 2022-09-07 | 17 | $90 | $65 | $72.785 | $86.26 | -15.62% |
| 2022-09-17 | 17 | $90 | $65 | $73.785 | $86.26 | -14.46% |
| 2022-10-04 | 16 | $90 | $65 | $74.357 | $86.26 | -13.8% |
| 2022-10-21 | 17 | $90 | $60 | $73.8 | $86.26 | -14.44% |
| 2022-10-26 | 16 | $90 | $60 | $74.2 | $86.26 | -13.98% |
| 2022-10-28 | 16 | $91 | $60 | $75.2 | $86.26 | -12.82% |
| 2022-10-31 | 18 | $96 | $60 | $77.733 | $86.26 | -9.89% |
| 2022-11-07 | 18 | $96 | $68 | $81.733 | $86.26 | -5.25% |
| 2022-11-08 | 19 | $96 | $27 | $78.937 | $86.26 | -8.49% |
| 2022-11-18 | 19 | $96 | $27 | $79.562 | $86.26 | -7.76% |
The Trend in the Analyst Price Target
Over the past 20 months, GILD's average price target has gone up $4.71.
Over the past 50 weeks, GILD's average upside potential has been 15.42%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-28 | 18 | 100 | 72 | 80.571 | 68.86 | 17.01% |
| 2022-03-08 | 18 | 90 | 65 | 77.142 | 59.54 | 29.56% |
| 2022-03-16 | 17 | 90 | 65 | 77.142 | 57.97 | 33.07% |
| 2022-09-17 | 17 | 90 | 65 | 73.785 | 65.60 | 12.48% |
| 2022-09-17 | 16 | 90 | 65 | 73.785 | 65.60 | 12.48% |
GILD Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 9 | 1 | 9 | 0 | 0 | 19 |
The Trend in the Broker Recommendations
Over the past 33 months, GILD's average broker recommendation rating improved by 0.23.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- GILD has a higher upside potential (average analyst target price relative to current price) than 239.6% of all US stocks.
- GILEAD SCIENCES INC's number of analysts covering the stock is higher than 4175.04% of Pharmaceutical Products stocks.
- In the context of Pharmaceutical Products stocks, GILEAD SCIENCES INC's average analyst price target is higher than 3598.11% of them.
- GILEAD SCIENCES INC's variance in analysts' estimates is lower than -1056.93% of Pharmaceutical Products stocks.
Stocks similar to GILEAD SCIENCES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are BIIB, AMGN, and TAK.
View All Top Stocks by Price Target
What is the outlook for GILD? Use POWR Ratings for clearer insight into price direction.